Literature DB >> 2066856

Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.

G N Thompson1, D E Francis, D Halliday.   

Abstract

Acute metabolic decompensation in maple syrup urine disease (MSUD) during otherwise minor illnesses has generally been presumed to result from massive release of leucine from protein catabolism. A stable isotope method based on the continuous infusion of (2H5)phenylalanine was used to measure protein metabolism in vivo in two children with MSUD during acute illness and when well. Net protein catabolism was greater in the unwell state (0.51 and 0.40 gm/kg per 24 hours in each child, respectively) than in the basal state (0.34 and 0.32). This rate of release of leucine from protein is compatible only with a slow (several days) rather than a dramatic rise in plasma leucine levels during acute illness in MSUD. Poor oral intake leading to a relative increase in time spent in the fasting state appears to be a more important determinant of increasing leucine levels than the catabolic effect of infection in itself. These factors suggested that branched-chain amino acid restriction should be commenced at the start of minor illness in children with MSUD, and that intake of other nutrients should be maintained or increased throughout the illness. A regimen based on these concepts was used during nine episodes of minor illness in two children with MSUD. Plasma branched-chain amino acid levels remained acceptable (less than 700 mumol/L) throughout each of these episodes. Dietary supplementation of this type may reduce the risk of metabolic decompensation during acute illnesses in children with MSUD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066856     DOI: 10.1016/s0022-3476(05)81035-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

Review 1.  Uses of stable isotopes in clinical diagnosis and research in the paediatric population.

Authors:  O A Bodamer; D Halliday
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

Review 2.  Intercurrent illness in inborn errors of intermediary metabolism.

Authors:  M A Dixon; J V Leonard
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

Review 3.  The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM).

Authors:  Tatyana N Tarasenko; Peter J McGuire
Journal:  Mol Genet Metab       Date:  2017-06-24       Impact factor: 4.797

4.  Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism.

Authors:  P Jouvet; F Poggi; J M Saudubray
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

5.  Parenteral administration of amino acids in disorders of branched-chain amino acid metabolism.

Authors:  W Sperl; D Skladal; W Endres; G Speer; K Groke
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.

Authors:  P Schadewaldt; H W Hammen; A C Ott; U Wendel
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

7.  Recommendations for protein and amino acid intake in phenylketonuria patients.

Authors:  H Przyrembel
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 8.  Emergency management of inherited metabolic diseases.

Authors:  V Prietsch; M Lindner; J Zschocke; W L Nyhan; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

9.  Branched-chain Ketoacyl Dehydrogenase Deficiency: Maple Syrup Disease.

Authors:  Kevin A. Strauss; D. Holmes Morton
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

Review 10.  Maple syrup urine disease: mechanisms and management.

Authors:  Patrick R Blackburn; Jennifer M Gass; Filippo Pinto E Vairo; Kristen M Farnham; Herjot K Atwal; Sarah Macklin; Eric W Klee; Paldeep S Atwal
Journal:  Appl Clin Genet       Date:  2017-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.